IM
Immunotech Laboratories, Inc.
IMMB · OTC
$0.00 +0.00% (+$0.00)
Market Cap ¥406.6K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
56 /100
Fair P/E 0.00x
EV/EBITDA 14.92x
P/S 0.00x
Growth
39 /100
Stable Rev. growth 8.56%
FCF growth 87.87%
Book val. growth 0.17%
Profitability
8 /100
Weak Gross margin 3.15%
Net margin 1.15%
Op. margin 2.21%
Quality
36 /100
Average ROIC 3.51%
ROA 1.76%
Asset turnover 1.54x
Debt
16 /100
High Debt/Equity 2.56x
Current ratio 1.24x
Int. coverage 3.09x
Stability
40 /100
Moderate Beta -5.14x
Rev. volatility 12.56%
EPS volatility 301.40%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre IMMB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer L. Bath
Employees
4
Headquarters
Monrovia